PBS Changes from 1 October
Please find below information relating to new and amended Pharmaceutical Benefits Scheme (PBS) listings implemented on 1 October 2026.
USANZ Members may be particularly interested in items relating to:
- Treatment with gonadotrophin releasing hormone (GnRH) agonist
- Triptorelin (3.75 mg injection [1 vial] (&) inert substance diluent [2 mL ampoule], 1 pack)
- (Diphereline®) has had a change to its restriction. It is now listed as an Unrestricted benefit.
This information relates to the administration of these listings by Services Australia. For further information, please download the Frequently Asked Questions. For information on broader PBS changes, please visit the PBS website. Relevant information and authority application forms have been updated and can be accessed through the Services Australia website.